|
PLS3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
4.90163465372007E-13 |
| Normal-vs-Stage3 |
1.46220002772424E-09 |
| Normal-vs-Stage4 |
2.42779999992671E-07 |
| Stage1-vs-Stage2 |
4.508800E-01 |
| Stage1-vs-Stage3 |
3.616700E-04 |
| Stage1-vs-Stage4 |
6.878000E-02 |
| Stage2-vs-Stage3 |
4.425600E-02 |
| Stage2-vs-Stage4 |
2.715200E-01 |
| Stage3-vs-Stage4 |
6.498200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.62470037423645E-12 |
| Normal-vs-Asian |
3.51510000000665E-05 |
| Caucasian-vs-AfricanAmerican |
1.947610E-01 |
| Caucasian-vs-Asian |
1.881380E-01 |
| AfricanAmerican-vs-Asian |
4.697000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.23043805647194E-12 |
| Male-vs-Female |
1.602800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.09932071726371E-12 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
1.63957736276643E-12 |
| Normal-vs-Extreme_Obese |
6.078899999995E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.548120E-02 |
| Normal_Weight-vs-Obese |
9.756800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.571200E-01 |
| Extreme_Weight-vs-Obese |
8.455600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.934600E-01 |
| Obese-vs-Extreme_Obese |
4.810800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.573880E-02 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.46611628287974E-13 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.777600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.609800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.111700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.857400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.545200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.797200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.63402624764331E-12 |
| Normal-VS-KIRP CIMP |
8.647000E-01 |
| Normal-VS-Unclassified PRCC |
1.62458935193399E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.6115300000008E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.621600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.758900E-04 |
| Type2 PRCC-VS-KIRP CIMP |
1.780410E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.010050E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.317600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.64700000000662E-05 |
| Normal-vs-N2 |
9.480500E-02 |
| N0-vs-N1 |
5.402100E-03 |
| N0-vs-N2 |
2.297000E-03 |
| N1-vs-N2 |
3.572000E-01 |
|
|
